1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Absolute Biotech

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2022

Location

Lynnwood WA US

Primary Industry

Biotechnology

About

Founded in 2022 and based in Washington, US, Absolute Biotech operates as a molecular pathology company that provides antibodies, proteins, biochemicals, ELISA (enzyme-linked immunosorbent assay) and Assay kits, and immunohistochemistry services to the pharmaceutical research sectors.
Current Investors
Thompson Street Capital Partners

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Chemicals
Website
www.absolutebiotech.com/
Verticals
Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only

Deals

Deals Type
Merger
Buyout
Add-on
Private Debt
Buyout
Deal Status Target (s) Deal Date Investor(s) Seller(s) Deal size (Mn) Enterprise value (Mn) Post-money valuation (Mn) EBITDA multiple (x) Revenue multiple (x) Lead partner (s)
Completed Vector Laboratories / Absolute Biotech 20 May 2024
Completed Absolute Antibody Ltd. 22 Dec 2020
Completed Everest Biotech Limited 16 Jul 2019
Completed Absolute Biotech 28 May 2019
Completed Absolute Biotech 17 Sep 2018
Displaying 1-5 of 5

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.